title: Promise of Wearable Physical Activity Monitors in Oncology Practice.
abstract: Commercially available physical activity monitors provide clinicians an opportunity to obtain oncology patient health measures to an unprecedented degree. These devices can provide objective and quantifiable measures of physical activity, which are not subject to errors or bias of self-reporting or shorter duration of formal testing. Prior work on so-called quantified-self data was based on older-generation, research-grade accelerometers, which laid the foundation for consumer-based physical activity monitoring devices to be validated as a feasible and reliable tool in patients with cancer. Physical activity monitors are being used in chronic conditions including chronic obstructive pulmonary disease, congestive heart failure, diabetes mellitus, and obesity. Differing demographics, compounded with higher symptom and treatment burdens in patients with cancer, imply that additional work is needed to understand the unique strengths and weaknesses of physical activity monitors in this population. Oncology programs can systematically implement these tools into their workflows in an adaptable and iterative manner. Translating large amounts of data collected from an individual physical activity monitoring device into clinically relevant information requires sophisticated data compilation and reduction. In this article, we summarize the characteristics of older- and newer-generation physical activity monitors, review the validation of physical activity monitors with respect to health-related quality-of-life assessments, and describe the current role of these devices for the practicing oncologist. We also highlight the challenges and next steps needed for physical activity monitors to provide relevant information that can change the current state of oncology practice.
authors.affiliation: University of Texas Southwestern Medical Center; Harold C. Simmons Cancer Center, Dallas, TX; and Yale University, New Haven, CT.
authors.forename: Muhammad S
authors.initials: MS
authors.lastname: Beg
authors.affiliation: University of Texas Southwestern Medical Center; Harold C. Simmons Cancer Center, Dallas, TX; and Yale University, New Haven, CT.
authors.forename: Arjun
authors.initials: A
authors.lastname: Gupta
authors.affiliation: University of Texas Southwestern Medical Center; Harold C. Simmons Cancer Center, Dallas, TX; and Yale University, New Haven, CT.
authors.forename: Tyler
authors.initials: T
authors.lastname: Stewart
authors.affiliation: University of Texas Southwestern Medical Center; Harold C. Simmons Cancer Center, Dallas, TX; and Yale University, New Haven, CT.
authors.forename: Chad D
authors.initials: CD
authors.lastname: Rethorst
mesh_terms: D004867:Equipment Design; D015444:Exercise; D000072936:Fitness Trackers; D006801:Humans; D008495:Medical Oncology / Q000295:instrumentation / Q000379:methods; D008991:Monitoring, Physiologic / Q000295:instrumentation* / Q000379:methods; D009369:Neoplasms / Q000175:diagnosis / Q000503:physiopathology*; D016032:Randomized Controlled Trials as Topic; D013673:Technology Assessment, Biomedical